| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/01/2007 | US20070050862 Promoter and methods of use in plants |
| 03/01/2007 | US20070050861 Seeds and plants produced by crossing the inbred line GKO-1 with itself or another broccoli line; insect resistance, herbicide resistance, male sterility, disease resistance |
| 03/01/2007 | US20070050860 Expressed Sequence Tags (ESTs) isolated from the Western Corn Rootworm; transgenic plant |
| 03/01/2007 | US20070050859 Selecting a codon of a parent polynucleotide that encodes a polypeptide for replacement with a synonymous codon, replacing the codon with synonymous codon (corresponds to an iso-tRNA ) to form a synthetic polynucleotide and introducing into a mammal cell |
| 03/01/2007 | US20070050858 Inactive ca2+/calmodulin-dependent protein kinase II-alpha knockin animal and knockin cell of the same |
| 03/01/2007 | US20070050857 Method of treatment and prophylaxis |
| 03/01/2007 | US20070050146 comprising a sequence of a pri-miRNA, pre-miRNA, miRNA, miRNA*, anti-miRNA, or a miRNA binding site; used to identify modulators of prostate and lung cancer |
| 03/01/2007 | US20070049744 Glucosyltransferases |
| 03/01/2007 | US20070049736 Cytokine receptor specific immunoglobulin for prevention and treatment of infection, cell proliferative and autoimmune disorders |
| 03/01/2007 | US20070049550 Hybrid immunomodulatory peptide and nucleotide sequences for treating allergies |
| 03/01/2007 | US20070049547 Methods for use in modulating miR-122a |
| 03/01/2007 | US20070049546 Substituted, non-coding nucleic acid molecule for therapeutic and prophylactic stimulation of the immune system in humans and higher animals |
| 03/01/2007 | US20070049545 Antisense modulation of fibroblast growth factor receptor 3 expression |
| 03/01/2007 | US20070049544 Antisense IAP nucleobase oligomers and uses thereof |
| 03/01/2007 | US20070049543 Controlling gene expression; enzyme inhibitors |
| 03/01/2007 | US20070049542 exposing the bacterial cells to a growth-inhibiting amount of an antisense oligonucleotide compound, composed of morpholino subunits and phosphorus-containing intersubunit linkages joining a morpholino nitrogen of one subunit to a 5' exocyclic carbon of an adjacent subunit; Escherichia coli, Salmonella |
| 03/01/2007 | US20070049541 Administering oligonucleotide containing optimal nucleotide binding site for the transcription factor for therapy of disease associated with hyper-activated signal transduction pathways, particularly malignancy |
| 03/01/2007 | US20070049540 Oligonucleotide inhibiting the expression of star-binding protein (sbp) gene and method therefor |
| 03/01/2007 | US20070049532 Selecting by phage display a peptide that binds to nerve growth factor (NGF), and preparing a fusion protein with an Fc domain; biological half-life increases |
| 03/01/2007 | US20070049529 Reducing the growth of cancer cells in a mammal by administering polypeptide of the invention; |
| 03/01/2007 | US20070049516 Use of Insulin for the Treatment of Cartilaginous Disorders |
| 03/01/2007 | US20070048865 Method for acceleration of stem cell differentiation |
| 03/01/2007 | US20070048862 Vectors based on recombinant defective viral genomes and their use in the formulation of vaccines |
| 03/01/2007 | US20070048861 plasmid constructs useful for the delivery of DNA vaccines; having a transcription cassette capable of directing the expression of a vaccine nucleic acid insert encoding immunogens derived from any pathogen, including fungi, bacteria and viruses |
| 03/01/2007 | US20070048860 Carcinoembryonic antigen (CEA) peptides |
| 03/01/2007 | US20070048854 Obtained from Campylobacter species; for use in synthesis of lipooligosaccharide (LOS); ganglioside biosynthesis and mimetics for treatment of nervous system disorders |
| 03/01/2007 | US20070048849 Contacting glycerol or 1,3-dihydroxyacetone with a single recombinant yeast or filamentous fungi expressing an exogenous glycerol dehydratase enzyme from Klebsiella or Citrobacter; fermentation |
| 03/01/2007 | US20070048847 Methods of producing antibodies to cytokine receptor |
| 03/01/2007 | US20070048846 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 03/01/2007 | US20070048845 Cytokine zalpha11 ligand fusion proteins |
| 03/01/2007 | US20070048842 using an E. coli expression system for the large scale production of IL-21 to a level of greater than 1 g/L in fed batch fermentation |
| 03/01/2007 | US20070048841 Viricidal polypeptide for prevention and treatment of hepatitis infection |
| 03/01/2007 | US20070048839 Novel amylolytic enzyme extracted from bacillus sp. A 7-7 (DSM 12368) and washing and cleaning agents containing this novel amylolytic enzyme |
| 03/01/2007 | US20070048838 Peptide-forming enzyme gene, peptide-forming enzyme, and peptide producing method |
| 03/01/2007 | US20070048837 Site specific protein modification |
| 03/01/2007 | US20070048828 Comprises fusion protein comprising platelet derived growth factor for treating connective tissue, tumor and bone disorders; used to stimulate the production of bone and/or connective tissue in both humans and non-human animals |
| 03/01/2007 | US20070048823 Compositions and Methods for Producing Apolipoprotein Gene Products in Lactic Acid Bacteria |
| 03/01/2007 | US20070048822 activating tyrosine phosphorylation of ErbB4 in an ErbB4-expressing cell by administering to the cell a polypeptide comprising the amino acid sequence of neuregulin 3 |
| 03/01/2007 | US20070048804 Methods of detecting cytokine receptor zcytor19 ligand |
| 03/01/2007 | US20070048799 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs |
| 03/01/2007 | US20070048783 Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions |
| 03/01/2007 | US20070048780 Genome sequences and nucleotide sequences coding for the PWD circovirus polypeptides, such as the circovirus structural and non-structural polypeptides, vectors including the sequences, and cells transformed by the vectors; kits for diagnosing infection and vaccines |
| 03/01/2007 | US20070048779 Method for detecting target plant genus |
| 03/01/2007 | US20070048777 Method of nucleic acid analysis by optical detection using disk |
| 03/01/2007 | US20070048776 Translation enhancer-element dependent vector systems |
| 03/01/2007 | US20070048775 Evolution of whole cells and organisms by recursive sequence recombination |
| 03/01/2007 | US20070048774 Continuous in-vitro evolution |
| 03/01/2007 | US20070048772 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 03/01/2007 | US20070048762 Real-time monitoring of nucleic acid target-identifying signals |
| 03/01/2007 | US20070048748 Mutant polymerases for sequencing and genotyping |
| 03/01/2007 | US20070048737 Calcium phosphate ceramics and particles for in vivo and in vitro transfection |
| 03/01/2007 | US20070048381 Methods for promoting growth of bone, ligament, and cartilage |
| 03/01/2007 | US20070048333 CD4+ T-lymphocyte-specific Hepatitis C virus-epitopes |
| 03/01/2007 | US20070048331 Non-toxic mutants of pathogenic gram-negative bacteria |
| 03/01/2007 | US20070048330 Optimized multi-epitope constructs and uses thereof |
| 03/01/2007 | US20070048326 Compositions and Methods for the Diagnosis and Treatment of Tumor |
| 03/01/2007 | US20070048318 Method for treating psoriasis |
| 03/01/2007 | US20070048311 ANTI-INTERFERON-alpha ANTIBODIES |
| 03/01/2007 | US20070048310 Human ataxin-1-like polypeptide IMX97018 |
| 03/01/2007 | US20070048305 CD147 binding molecules as therapeutics |
| 03/01/2007 | US20070048301 Compositions and methods for the treatment of immune related diseases |
| 03/01/2007 | US20070048299 Methods of inducing an immune response |
| 03/01/2007 | US20070048298 administering nucleoproteins such as retinoblastoma associated protein 48 suppressor or inhibitors, used for prophylaxis of Sjogren's syndrome, as diagnostic agents or screening antiapoptosic agents |
| 03/01/2007 | US20070048293 Manipulation of PTEN in T cells as a strategy to modulate immune responses |
| 03/01/2007 | US20070048287 Molecular antigen array |
| 03/01/2007 | US20070048286 Method of treating dopaminergic and GABA-nergic disorders |
| 03/01/2007 | US20070048285 Self-inactivating retroviral vector |
| 03/01/2007 | US20070048284 Cardiac arrhythmia treatment methods |
| 03/01/2007 | US20070048283 Exposing to immunogenic portion of protein and/or encoding nucleotide homologenous to sequence 20 or 22b; eliciting response to 74P3B3 protein; pancreatic cancer |
| 03/01/2007 | US20070048282 With improved shelf life and storage stability; expression vectors and host cells; therapeutic proteins are chemically or genetically fused to albumin |
| 03/01/2007 | US20070048260 Cytokine zalpha11 ligand fusion proteins |
| 03/01/2007 | US20070048259 Cytokine zalpha11 ligand |
| 03/01/2007 | US20070048256 Expression vector comprising nucleotide sequences coding cytokine protein for diagnosis, prevention and treatment of thymus disorders |
| 03/01/2007 | US20070048253 Natively glycosylated mammalian biological molecules produced by electromagnetically stimulating living mammalian cells |
| 03/01/2007 | US20070048248 ARC186 aptamer PEG conjugate; transplant rejection; angioplasty; restenosis; specificity and affinity of the aptamer can be tightly controlled and allows the generation of leads; no toxicity or immunogenicity; chemical stability |
| 03/01/2007 | US20070048218 Compositions and Methods for the Diagnosis and Treatment of Tumor |
| 03/01/2007 | DE19960225B4 Kristallines, in der asymmetrischen Einheit mindestens eine an der Katalyse beteiligte (Sub)-Domaine eines humanen m-Calpains aufweisendes Polypeptid, Verfahren zur Identifizierung von Verbindungen unter dessen Verwendung, Verfahren zu dessen Kristallisation und Verfahren zur Darstellung einer 3-dimensionalen Struktur dieses Peptids Crystalline, in the asymmetric unit, at least one involved in catalysis (Sub) -Domaine a human m-calpain polypeptide having, methods for identifying compounds with its use, method of crystallization and method for displaying a 3-dimensional structure of this peptide |
| 03/01/2007 | DE102005040347A1 Verfahren und Mittel zur Anreicherung, Entfernung und zum Nachweis von Listerien Method and means for the enrichment, removal and detection of Listeria |
| 03/01/2007 | CA2626900A1 Reduced genome e. coli |
| 03/01/2007 | CA2620420A1 Translation enhancer-element dependent vector systems |
| 03/01/2007 | CA2620267A1 Genes involved in asymmetric cell division |
| 03/01/2007 | CA2620210A1 Plant producing hyaluronic acid |
| 03/01/2007 | CA2620125A1 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 03/01/2007 | CA2619989A1 Regulation of heterologous recombinant protein expression in methylotrophic and methanotrophic bacteria |
| 03/01/2007 | CA2619943A1 Compositions and methods for producing apolipoprotein gene products in lactic acid bacteria |
| 03/01/2007 | CA2619833A1 Use of crispr associated genes (cas) |
| 03/01/2007 | CA2619491A1 Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8-associated disorders |
| 03/01/2007 | CA2618203A1 System for screening cells for high expression of a protein of interest (poi) |
| 03/01/2007 | CA2602425A1 O-acetylhomoserinesulfhydorelace gene and use thereof |
| 03/01/2007 | CA2583501A1 Enhanced zein reduction in transgenic corn seed |
| 02/28/2007 | EP1757941A1 Method for immunochemically assaying anti-hm1.24 antibody |
| 02/28/2007 | EP1757935A1 Gene detection method and gene detection apparatus |
| 02/28/2007 | EP1757705A2 Intraoperative lymph node assay |
| 02/28/2007 | EP1757703A2 Self-inactivating retroviral vector |
| 02/28/2007 | EP1757702A1 Self-inactivating gammaretroviral vector |
| 02/28/2007 | EP1757701A1 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 02/28/2007 | EP1757700A2 Cell culture process for glycoproteins |
| 02/28/2007 | EP1757699A1 cDNAs encoding secreted proteins |
| 02/28/2007 | EP1757698A1 Polypeptides having dna polymerase activity |
| 02/28/2007 | EP1757697A2 Group B streptococcus antigens |